Iqvia Holdings earnings were $1.3B for the trailing 12 months ending Sep 30, 2025, with -4.8% growth year over year. The latest IQV earnings report on Sep 30, 2025 announced Q3 2025 earnings of $331.0M, up 24.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IQV reported annual earnings of $1.4B, with 1.1% growth.
IQV past earnings growth
How has IQV's earnings growth performed historically?
On IQV's earnings call on Invalid Date, Iqvia Holdings (NYSE: IQV) reported Q3 2025 earnings per share (EPS) of $1.94, up 23.57% year over year. Total IQV earnings for the quarter were $331.00 million. In the same quarter last year, Iqvia Holdings's earnings per share (EPS) was $1.57.
As of the last Iqvia Holdings earnings report, Iqvia Holdings is currently profitable. Iqvia Holdings's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $1.28 billion, a 8.68% decrease year over year.
What was IQV's earnings growth in the past year?
As of Iqvia Holdings's earnings date in Invalid Date, Iqvia Holdings's earnings has grown -4.8% year over year. This is 14.53 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 9.73%. IQV earnings in the past year totalled $1.28 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.